Drug Profile
Interferon-gamma-1b - InterMune/Maxygen
Alternative Names: IFN-gamma-1b - InterMune/Maxygen; IFN-γ-1b - InterMune/Maxygen; Interferon gamma-1b - InterMune/Maxygen; Maxy 50; Maxy-Gamma; Maxy-γLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Maxygen
- Class Antineoplastics; Antivirals; Interferons; Lymphokines
- Mechanism of Action Interferon gamma stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Hepatitis C; Pulmonary fibrosis
Most Recent Events
- 06 Jun 2006 This programme is still in active development
- 27 Sep 2004 Preclinical trials in Hepatitis C in USA (unspecified route)
- 03 Oct 2002 Preclinical trials in Cancer in USA (unspecified route)